Screen Failure Reimbursement Sample Clauses

Screen Failure Reimbursement. A “Screen Failure” is defined as a candidate who enters the screening process based on Protocol defined eligibility criteria, signs the ICF and receives any Study procedure but who is not randomized or enrolled into the Study.
AutoNDA by SimpleDocs
Screen Failure Reimbursement. A “Screen Failure” is defined as a candidate who enters the screening process based on Protocol defined eligibility criteria, signs the ICF and receives any Study procedure but who is not randomized or enrolled into the Study. 4. N áhrada za neúspěšný screening. „Neúspěšný screening“ je definován jako kandidát, který zahájí proces screeningu na základě kritérií způsobilosti definovaných protokolem, podepíše formulář informovaného souhlasu a absolvuje jakýkoli postup v rámci studie, ale který není randomizován ani zařazen do studie. No payment is to be made for candidates who do not meet the initial eligibility criteria to enter the screening process, or where there are significant deviations from the Protocol. Za kandidáty, kteří nesplňují počáteční kritéria způsobilosti k zahájení procesu screeningu, nebo u kterých dojde k významným odchylkám od protokolu, nebudou uhrazeny žádné částky. Screen failures will be paid provided that the reason for the screen fail could not be determined without the screening procedures performed and completed screening CRF pages were submitted along with any additional information, which may be requested by the Sponsor, or its designee toappropriately document the screening procedures. Za neúspěšný screening bude zaplaceno za předpokladu, že neúspěch nebylo možno zjistit bez provedení screeningových postupů a vyplněné stránky záznamu subjektu byly předloženy spolu se všemi dodatečnými informacemi, jež si zadavatel nebo jeho zmocněnec může vyžádat za účelem řádné dokumentace screeningových postupů. Institution shall request payment for each Screen Failure by submitting an invoice to Sponsor, specifying the candidate’s identifiable information and the date of the Screen Failure. Zdravotnické zařízení si vyžádá platbu za každý neúspěšný screening tím, že předloží zadavateli fakturu a uvede identifikovatelné informace o kandidátovi a datum neúspěšného screeningu. Payment rate for Screen Failures shall be paid in accordance with the Budget. Payments for any Screen Failures exceeding the limit listed in the Budget are subject to Sponsor’s written approval and should be directed to Sponsor. If the parties mutually agree in writing (including email) to change the approved number of allowable Screen Failure payments during the course of the study, an amendment to this Agreement is not required. Sazba plateb za neúspěšný screening bude v souladu s rozpočtem. Platby za neúspěšné screeningy přesahující mez uvedenou v rozpočtu vyžadují pí...
Screen Failure Reimbursement. A “Screen Failure” is defined as a Study Subject who signs an approved ICF, completes initial screening visit(s), but is determined to not meet eligibility criteria based on the results of a Study-required procedure or analysis during the screening visit, and is not randomized into the Study. Screen Failures at Visit 1 will be reimbursed in accordance with the Screen Failure rate(s) set forth in Appendix 3. Screen Failures will be paid if the site splits the S1 visit into more than one visit (S1a and S2b) and conducts the predefined assessments and then the first peripheral EOS count. If in the Investigator’s opinion, the patient will not satisfy the EOS criterion based on the first EOS value (e.g. it is too high), then the subject will Screen Fail and the site will be paid for the assessments conducted. Screen Failures for the remaining criteria or those determined as S2, S3 or randomization failures, will be paid based upon the previously agreed rates related to completed procedures and after the data has been entered into the CRF per Section 3.7 of the contract. - The below listed costs for S1 will be reimbursed, providing the subject meets the corresponding Inclusion and Exclusion criteria and in the Investigator’s opinion the initial peripheral EOS count results suggest that the subject will not meet the overall EOS Inclusion Criterion (c). In the event subject does not meet the eligibility related to procedures as listed below except EOS, the Screen Failure will not be paid. Informed Consent - Demography, Medical history, Asthma and allergy history, - Prior/concomitant medication inquiry - Vital sign measurement - Central lab (collect, process and ship) - PI and SC fee Total number of S1a Screen Failure Payments will not exceed maximum of Subjects s without Sponsor approval. Subjects will be reimbursed for the Úhrada za subjekty, které neprošly screeningem: Subjekt, který neprošel screeningem, je definován jako subjekt, který podepsal schválený formulái informovaného souhlasu, absolvoval úvodní screeningové návštevy, ale bylo zjišteno, že nesplňuje kritéria způsobilosti na základe výsledků postupu či analýzy souvisejících se studií, jež byly provedeny pii screeningové návšteve, a není randomizován do studie. Úhrada za subjekty, které neprošly screeningem, bude provedena dle stanovené sazby za subjekty, které neprošly screeningem pii návšteve 1, uvedené v piíloze 3. Úhrada za subjekty, které neprošly screeningem, bude provedena v piípade, že pracovišt...
Screen Failure Reimbursement. A screen failure is a potential Study Subject who provides signed informed consent and fails inclusions and/or meets exclusion criteria or for dokončení studie a do vyřešení všech dotazů/námitek pracoviště a bude tvořit závěrečnou platbu. Úhrada za subjekt, který neprošel screeningem: Subjekt, který neprošel screeningem, je potenciální subjekt klinické studie, který poskytne podepsaný informovaný other reasons is not randomized. INSTITUTION/INVESTIGATOR agrees that it will not receive payment for more than 5 screen failures without the prior written consent of the SPONSOR/ICON. Screen failures will be reimbursed by invoice only. The invoice should reflect the cost actually incurred for the procedures performed prior to the Study Subject’s failure up to the total cost of the screening visit which is CZK XXXX. souhlas a nesplní kritéria pro zařazení do studie / splní kritéria pro vyloučení ze studie nebo není randomizován z jiných důvodů. ZDRAVOTNICKÉ ZAŘÍZENÍ/ZKOUŠEJÍCÍ souhlasí s tím, že neobdrží platbu za více než 5 subjektů, které neprošly screeningem, bez předchozího písemného souhlasu ZADAVATELE/ICON. Platby za subjekty, které neprošly screeningem, budou hrazeny pouze na základě faktury. Faktura by měla odrážet náklady skutečně vzniklé za úkony provedené před neúspěšným screeningem subjektu studie až do celkové částky za screeningovou návštěvu, která činí XXX Kč.
Screen Failure Reimbursement. A “Screen Failure” is defined as a candidate who enters the screening process based on Protocol defined eligibility criteria, signs the ICF and receives any Study procedure but who is not randomized or enrolled into the Study. No payment is to be made for candidates who do not meet the initial eligibility criteria to enter the screening process, or where there are significant deviations from the Protocol. Screen failures will be paid provided that the reason for the screen fail could not be musí poskytovatel nebo zkoušející získat souhlas zadavatele piedtím, než zahájí dodatečný screening pro zaiazení dalších subjektů studie po . subjektu studie. Souhlas zadavatele musí být doložen písemne ve forme e-mailu nebo jiného písemného souhlasu. Platby pro všechny subjekty studie zaiazené poskytovatelem s písemným souhlasem zadavatele podléhají podmínkám této smlouvy, platebním podmínkám a rozpočtu studie.

Related to Screen Failure Reimbursement

  • Payment Failure Any Credit Party (i) fails to pay any principal when due under this Agreement or (ii) fails to pay, within three Business Days of when due, any other amount due under this Agreement or any other Credit Document, including payments of interest, fees, reimbursements, and indemnifications;

  • Epidemic Failure Remedy If an Epidemic Failure occurs, all costs, including but not limited to, replacement Products, parts, upgrades, materials, labor, transportation and inventory replacement arising from an Epidemic Failure shall be borne by Supplier, regardless of whether DXC initiates a field stocking recall or customer-based recall or retrofit, including Products in distributor inventory and DXC’s installed base. Supplier, at its expense, will ensure that such Products, parts or upgrades have the highest shipping priority. DXC reserves the right to procure, upon terms it deems appropriate, similar products to substitute the affected Products, and Supplier shall promptly reimburse DXC for all costs, charges, prices and fees paid in purchasing the substitute products.

  • Equipment Failures In the event of equipment failures beyond the Administrator's control, the Administrator shall take reasonable and prompt steps to minimize service interruptions but shall have no liability with respect thereto. The Administrator shall develop and maintain a plan for recovery from equipment failures which may include contractual arrangements with appropriate parties making reasonable provision for emergency use of electronic data processing equipment to the extent appropriate equipment is available.

  • Epidemic Failure Warranty Supplier warrants all Products against Epidemic Failure for a period of three years after DXC’s Acceptance. Epidemic Failure means the occurrence of the same failure, defect, or non-conformity with an Order in 2% or more of Products within any three-month period.

  • Epidemic Failure “Epidemic Failure” for any particular Product shall mean a failure resulting from defects in material, workmanship, and manufacturing process, including but not limited to the use of Components with known defects. The Epidemic Failure clause shall be invoked [***]. The failure rate may be calculated [***], as determined by BUYER. Epidemic failures do not supersede the requirements of any expressed or implied warranty defined herein. In the case of an epidemic failure, SUPPLIER’s obligation is to propose an action plan to fix the failure of any affected Product within seventy-two (72) hours of discovery. SUPPLIER shall implement this action plan upon BUYER’s acceptance thereof. If the action plan is not acceptable to BUYER, BUYER can require SUPPLIER to repair or replace, at BUYER’s option, the affected Product. In addition to bearing the costs associated therewith, if requested by BUYER, SUPPLIER shall support and provide at SUPPLIER’s expense a sufficient number of units of the Product to permit the field exchange or “hot swap” of Products at customer sites. The parties agree to make all reasonable efforts to complete the repair or replacement of all affected Products within eight (8) Business Days after written notice of epidemic failure by BUYER to SUPPLIER. SUPPLIER also agrees that BUYER will be supported with accelerated shipments of replacement Product to cover BUYER’s supply requirements. If an Epidemic Failure is caused by (i) a design, including a BUYER-provided test process, as required by the Specifications or (ii) a failure by a Component required by the Specifications, (iii) misuse or damage during transit or damage by a third party at no fault of SUPPLIER, SUPPLIER shall perform the obligations in this Section 10.5 and BUYER shall pay to SUPPLIER the fees mutually agreed upon by the parties in writing. If an Epidemic Failure is caused by any other reason other than as set forth in the immediately preceding sentence, SUPPLIER shall perform the obligations set forth in this Section free of charge. Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

  • Thirty Day Payments Upon receipt of a billing statement that complies with all invoice requirements set forth in this Article, the State shall make a good faith effort to pay the amount which is due and payable within thirty

  • Lenders’ Failure to Perform All Advances (other than Swing Loans and Agent Advances) shall be made by the Lenders contemporaneously and in accordance with their Pro Rata Shares. It is understood that (i) no Lender shall be responsible for any failure by any other Lender to perform its obligation to make any Advance (or other extension of credit) hereunder, nor shall any Commitment of any Lender be increased or decreased as a result of any failure by any other Lender to perform its obligations hereunder, and (ii) no failure by any Lender to perform its obligations hereunder shall excuse any other Lender from its obligations hereunder.

  • Borrower’s Failure to Notify Any outstanding Borrowing of Domestic Rate Loans shall, subject to Section 6.2 hereof, automatically be continued for an additional Interest Period on the last day of its then current Interest Period unless the Borrower has notified the Administrative Agent within the period required by Section 1.6(a) hereof that it intends to convert such Borrowing into a Borrowing of Eurocurrency Loans or notifies the Administrative Agent within the period required by Section 1.9(a) hereof that it intends to prepay such Borrowing. If the Borrower fails to give notice pursuant to Section 1.6(a) hereof of the continuation or conversion of any outstanding principal amount of a Borrowing of Eurocurrency Loans denominated in U.S. Dollars before the last day of its then current Interest Period within the period required by Section 1.6(a) hereof and has not notified the Administrative Agent within the period required by Section 1.9(a) hereof that it intends to prepay such Borrowing, such Borrowing shall automatically be converted into a Borrowing of Domestic Rate Loans, subject to Section 6.2 hereof. If the Borrower fails to give notice pursuant to Section 1.6(a) above of the continuation of any outstanding principal amount of a Borrowing of Eurocurrency Loans denominated in an Alternative Currency before the last day of its then current Interest Period within the period required by Section 1.6(a) hereof and has not notified the Administrative Agent within the period required by Section 1.9(a) hereof that it intends to prepay such Borrowing, such Borrowing shall automatically be continued as a Borrowing of Eurocurrency Loans in the same Alternative Currency with an Interest Period of one month, subject to Section 6.2 hereof, including the application of Section 1.4 hereof and of the restrictions contained in the definition of Interest Period.

  • Default Payment Following the occurrence and during the continuance of an Event of Default, the Holder, at its option, may demand repayment in full of all obligations and liabilities owing by Company to the Holder under this Note, the Purchase Agreement and/or any other Related Agreement and/or may elect, in addition to all rights and remedies of the Holder under the Purchase Agreement and the other Related Agreements and all obligations and liabilities of the Company under the Purchase Agreement and the other Related Agreements, to require the Company to make a Default Payment (“Default Payment”). The Default Payment shall be 130% of the outstanding principal amount of the Note, plus accrued but unpaid interest, all other fees then remaining unpaid, and all other amounts payable hereunder. The Default Payment shall be applied first to any fees due and payable to the Holder pursuant to this Note, the Purchase Agreement, and/or the other Related Agreements, then to accrued and unpaid interest due on this Note and then to the outstanding principal balance of this Note. The Default Payment shall be due and payable immediately on the date that the Holder has exercised its rights pursuant to this Section 2.3.

  • Settlement without Consent if Failure to Reimburse If at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by Section 6(a)(ii) effected without its written consent if (i) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such settlement at least 30 days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!